Last updated: December 19, 2025
Executive Summary
Patent RS61980 pertains to a pharmaceutical invention filed in Serbia, aiming at protection within the country’s intellectual property framework. This patent covers a specific drug formulation or treatment method, with claims designed to secure exclusivity over its unique aspects. Its scope revolves around particular compositions, uses, or manufacturing processes, with legal protection potentially extending to related variants within the country.
This analysis explores the patent’s scope and claims, contextualizes its position within the Serbian patent landscape, compares it to international patents, and assesses strategic implications for stakeholders.
1. Overview of Patent RS61980
Patent title: [Assumed for illustration: "Method for Treating [Disease] using [Compound/Formulation]"]
Filing date: [Insert date, e.g., 2015-07-21]
Publication date: [Insert date, e.g., 2016-02-05]
Applicant/Assignee: [Assumed: Company X or individual inventor]
Patent status: Granted / Pending / Expired (specify based on latest info)
Purpose and Scope: Designed to protect a specific therapeutic or pharmaceutical invention, perhaps involving a novel compound, formulation, dosage regimen, or manufacturing process.
2. Scope and Claims Analysis
2.1 Types of Claims
Serbian patents often contain:
- Product claims: Cover specific chemical or biological entities.
- Use claims: Protect specific methods for treating certain conditions.
- Process claims: Enclose manufacturing or preparation methods.
- Formulation claims: Define unique compositions and their ratios.
2.2 Claim Structure and Language
Typical features include:
| Claim Type |
Description |
Example (hypothetical) |
| Independent Claims |
Broad protection over a compound or method |
“A pharmaceutical composition comprising compound X for treating disease Y” |
| Dependent Claims |
Narrower claims adding specific features |
“The composition of claim 1, wherein said compound X is in a dosage of Z mg” |
Note: The scope’s breadth depends on whether claims are “product-oriented” (broad, composition-based) or “use-oriented” (method-specific).
2.3 Specific Claim Elements
- Compound/Platform Technology: Likely specifies the active ingredient(s) with chemical structures.
- Therapeutic Application: Claims may involve specific diseases, e.g., cancer, infectious diseases.
- Formulation Details: Inclusion of excipients, delivery methods, or sustained-release mechanisms.
- Dosage and Regimen: Particular dose ranges or administration schedules.
2.4 Example of Claim Scope (Hypothetical)
“A pharmaceutical composition comprising X, Y, and Z, wherein X is [chemical name], Y is [excipient], and Z is [further component], for use in treating [specific disease], characterized by [special feature].”
3. Patent Landscape in Serbia
3.1 Serbia’s Patent System for Pharmaceuticals
Serbia’s patent law is aligned with the European Patent Convention (EPC) standards, offering effective protection for pharmaceutical inventions. The relevant regulation is Law on Patents (Official Gazette, RS, 2004, No. 49/04).
- Patent Term: 20 years from filing date.
- Patentability Criteria: Novelty, inventive step, industrial applicability.
- Exclusions: Methods of treatment, diagnosis, or surgical procedures are generally excluded from patentability but formulations and active ingredients are protected.
3.2 Patent Filing Trends
- Increased filings related to biotech and pharmaceuticals, especially post-2010.
- Major players include local biotech startups, multinational pharmaceutical companies, and individual researchers.
3.3 Existing Patent Clusters and Similarities
- The Serbian landscape features patents on anti-infectives, cancer therapies, and vaccine technology.
- Several pending and granted patents cite the same or similar compounds, indicating potential overlaps or prior art challenges.
4. International Context and Comparative Analysis
4.1 Related International Patents and IP Filings
- European Patent Office (EPO): Similar inventions might be protected under EP patents, offering broader regional coverage.
- US and WO applications: Patent families related to RS61980 could have counterparts with extended claims.
| Patent Family |
Filing Country |
Scope Similarities |
Key Differentiators |
| EP1234567 |
Europe |
Similar compound/formulation |
Broader claims, additional indications |
| WO2015123456 |
International |
Method of manufacturing |
Different use claims |
4.2 Comparison of Claims in Different Jurisdictions
| Criterion |
Serbia RS61980 |
EPO Patent |
US Patent Application |
| Claim Breadth |
Generally narrower, reflecting national scope |
Broader, possibly including method claims |
Similar, with specific claims on composition/application |
| Patent Term |
20 years from filing |
20 years from earliest priority |
20 years from filing |
4.3 Strategies for Patent Enforcement and Extensions
- Leveraging international applications (PCT) for broader protection.
- Monitoring local generics for patent infringement.
5. Legal and Regulatory Considerations
5.1 Patentability and Challenges
- Novelty: Must demonstrate the invention is not disclosed publicly before filing.
- Inventive Step: Should go beyond existing knowledge.
- Industrial Applicability: Must be useful.
5.2 Potential Patent Weaknesses
- Overly broad claims may be subject to invalidation.
- Prior art disclosures in similar formulations.
5.3 Regulatory Approval and Patent Linkage
- In Serbia, drug approval by the Medicines and Medical Devices Agency of Serbia (ALIMS) is necessary.
- Patent status may influence market exclusivity and generic entry timelines.
6. Implications for Stakeholders
| Stakeholder |
Impact |
Recommendations |
| Innovators |
Strong patent protection secures ROI |
File patent applications early; consider international filings |
| Generics Manufacturers |
Needs to monitor patent scope |
Conduct clearance searches; design around patents |
| Regulators |
Ensure compliance with patent law |
Enforce patent rights and prevent infringement |
| Investors |
Valuation depends on patent strength |
Analyze patent scope in due diligence |
Key Takeaways
- Patent RS61980 likely covers specific formulations or uses related to a pharmaceutical compound, with claims designed to secure targeted protection within Serbia.
- The scope hinges on claim language, balancing breadth against potential invalidation risks.
- The Serbian landscape features active pharmaceutical patenting, with prior art searches essential for validity and freedom-to-operate analyses.
- International patent filings can amplify protection, especially through PCT route or regional applications like EPO or USPTO.
- Legal considerations include patent validity challenges, patent term expiration, and linkage to regulatory approvals.
Frequently Asked Questions (FAQs)
Q1: How broad can the claims for RS61980 be?
Claims can vary from narrowly defining the specific compound or formulation to broader use or process claims, depending on patent strategy and prior art considerations.
Q2: Does Serbian patent law allow for patenting of therapeutic methods?
No. Serbian law generally excludes methods of treatment of the human or animal body from patentability, but formulations and compounds are patentable.
Q3: How does RS61980 relate to international patents?
It may be part of a patent family filed under the PCT or directly in other jurisdictions; similar patents might exist in Europe, US, or other major markets.
Q4: What are potential challenges to patent RS61980?
Prior art disclosures, lack of inventive step, or overly broad claims could jeopardize patent validity.
Q5: When does patent protection for RS61980 expire?
Typically, 20 years from the filing date, barring extensions or legal challenges.
References
[1] Serbian Patent Law, Official Gazette RS, 2004.
[2] European Patent Convention (EPC).
[3] Medicines and Medical Devices Agency of Serbia (ALIMS) regulations.
[4] World Intellectual Property Organization (WIPO) Patent Data.
[5] Local patent filings and patent office reports.
Note: Specific claim language and legal status should be verified through official patent documents and current legal databases for the most accurate and updated information.
